Indianapolis, IN, United States of America

Jeffrey A Dodge

This inventor holds 74 USPTO granted patents, plus 1 CIPO patent, primarily in Estrogen Receptor Modulators (CPC class 5144). Top assignee: Eli Lilly and Company. Active years: 1995-2013.


% Patents Active = 87.8


Average Co-Inventor Count = 2.2

ph-index = 13

Forward Citations = 495(Granted Patents)

Forward Citations (Not Self Cited) = 478(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 1995-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
Selective Estrogen Receptor Modulator
Growth Hormone Secretagogue
Benzothiophenes
Naphthyl Compounds
Pharmaceutical Compounds
Cholesterol Lowering
Endometriosis Treatment
Osteoarthritis Treatment
Vasomotor Symptoms
Benzofuran Compounds
Nitrogen-Containing Compounds
Substituted Benzopyrans
74 patents (USPTO):Explore Patents

Title: Unveiling the Innovative Path of Jeffrey A Dodge in Pharmaceutical Science

Introduction:

Jeffrey A Dodge is a prominent inventor based in Indianapolis, IN, with a remarkable track record in the field of pharmaceutical innovation. His dedication and ingenuity have led to the successful development of numerous groundbreaking inventions, making him a valuable asset in the industry.

Latest Patents:

Jeffrey A Dodge's latest patents showcase his expertise in creating novel solutions for the medical field. One of his recent inventions includes a Selective estrogen receptor modulator for the treatment of osteoarthritis, offering a promising approach to managing this debilitating condition. Additionally, his work on Selective estrogen receptor modulators for the treatment of vasomotor symptoms highlights his commitment to advancing women's health around menopause.

Career Highlights:

Currently employed at Eli Lilly and Company, Jeffrey A Dodge has contributed significantly to the company's research and development efforts. With an impressive portfolio of 74 patents to his name, he continues to drive innovation in the pharmaceutical sector and improve the quality of healthcare worldwide.

Collaborations:

Throughout his career, Jeffrey A Dodge has collaborated with esteemed professionals in the field, including Henry U Bryant and Charles Willis Lugar, III. These partnerships have not only enriched his work but also resulted in the successful realization of groundbreaking inventions that have the potential to revolutionize the industry.

Conclusion:

In conclusion, Jeffrey A Dodge stands as a beacon of innovation in the realm of pharmaceutical science. His passion for discovery, coupled with his relentless pursuit of excellence, has cemented his reputation as a trailblazer in the field. As he continues to push the boundaries of possibility, the future holds even more revolutionary inventions from this visionary inventor.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…